http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104507958-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
filingDate | 2012-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104507958-B |
titleOfInvention | Bioactivity peptide complexes |
abstract | The present invention relates to the protein with immune regulative and antiviral activity and biologically active peptide.The peptide complexes of the present invention have three-dimensional structure, and its structural formula is as follows: Wherein, X 1 It is not present or containing at least one amino acid;R 1 And R 2 - peptide chain, contains His the or Cys amino acid residues interacted with transition metal ions, wherein R 1 Containing at most 5 amino acid residues or it is not present;R 2 Containing at most 3 amino acid or it is not present.Peptide complexes rich in histidine, the calliphorid antiviral peptide family peptides especially with Zn ions will make manufacture have the medicine of targeting mechanism and design them according to the understanding to drug targeting structure and become possibility. |
priorityDate | 2012-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.